Could cause temporary or reversible harm; serious harm is unlikely.
Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.
| Brand name | ATORVASTATIN CALCIUM |
| Generic name | ATORVASTATIN CALCIUM |
| Active ingredient(s) | ATORVASTATIN CALCIUM TRIHYDRATE |
| Distributed by / for | Mylan Institutional, Inc. (d.b.a. UDL Laboratories) |
| NDC | 51079-208-20 |
| Full product label | Atorvastatin Calcium Tablets, 10 mg*, 100-count Unit Dose Tablets (10 x 10) per carton, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.., NDC 51079-208-20 |
| Recalling firm | Mylan Institutional, Inc. (d.b.a. UDL Laboratories) |
| Distribution | Nationwide in the USA |
| Quantity | 1,527 cartons |
| Recall initiated | 2017-03-21 |
| Report date | 2017-04-05 |
| Recall completed | 2019-03-15 |
| Recall number | D-0622-2017 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Rockford IL United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗